Morbidity and mortality of vulvar and vaginal cancers: Impact of 2-, 4-, and 9-valent HPV vaccines

References

• Berek J. Berek & Hacker's gynecologic oncology (5th ed.). Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins Health 2010
   Google Scholar
• National Cancer Institute. SEER Stat Facts: Vulvar Cancer. Available at: http://seer.cancer.gov/statfacts/html/vulva.html; 2014. [Retrieved 2015]
   Google Scholar
• Judson P, Habermann E, Baxter N, Durham S, Virnig B. Trends in the Incidence of Invasive and In Situ Vulvar Carcinoma. Obstetr Gynecol 2008; 107:1018-1022
   Web of Science ®Google Scholar
• Akhtar-Danesh N, Elit L, Lytwyn A. Trends in incidence and survival of women with invasive vulvar cancer in the United States and Canada: A population-based study. Gynecologic Oncol 2014; 134:314-318; PMID:24875124; http://dx.doi.org/10.1016/j.ygyno.2014.05.014
   PubMed Web of Science ®Google Scholar
• Zweizig S, Korets S, Cain J. Key concepts in management of vulvar cancer. Best Practice Res Clin Obstet Gynaecol 2014; 28:959-966; PMID:25151473; http://dx.doi.org/10.1016/j.bpobgyn.2014.07.001
   PubMed Web of Science ®Google Scholar
• Alkatout I, Günther V, Schubert M, Weigel M, Garbrecht N, Jonat W, Mundhenke C. Vulvar cancer: Epidemiology, clinical presentation, and management options. Int J Women's Health IJWH 2015; 7:305-305; http://dx.doi.org/10.2147/IJWH.S68979
   PubMed Web of Science ®Google Scholar
• Vuyst H, Clifford G, Nascimento M, Madeleine M, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis. Int J Cancer 2009; 124:1626-1636; http://dx.doi.org/10.1002/ijc.24116
   PubMed Web of Science ®Google Scholar
• Conley L, Ellerbrock T, Bush T, Chiasson M, Sawo D, Wright T. HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: A prospective cohort study. Lancet 2002; 359:108-113; http://dx.doi.org/10.1016/S0140-6736(02)07368-3
   PubMed Web of Science ®Google Scholar
• Massad L. Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus*1. Am J Obstetr Gynecol 2004; 190:1241-1248; PMID:15167825; http://dx.doi.org/10.1016/j.ajog.2003.12.037
   PubMed Web of Science ®Google Scholar
• Frisch M. Human Papillomavirus-Associated Cancers in Patients with Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome. J Natl Cancer Inst 2000; 92:1500-1510; PMID:10995805; http://dx.doi.org/10.1093/jnci/92.18.1500
   PubMed Web of Science ®Google Scholar
• Rauh-Hain J, Clemmer J, Clark R, Bradford L, Growdon W, Goodman A, Carmen M. Racial disparities and changes in clinical characteristics and survival for vulvar cancer over time. Am J Obstetr Gynecol 2013; 209:468.e1-468.e10; PMID:23891626
   PubMedGoogle Scholar
• Fu Y, Reagan J. Pathology of the uterine cervix, vagina, and vulva. Philadelphia: Saunders 2002
   Google Scholar
• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63:11-30; PMID:23335087
   PubMed Web of Science ®Google Scholar
• Key Statistics About Vaginal Cancer. Available at http://www.cancer.org/cancer/vaginalcancer/detailedguide/vaginal-cancer-key-statistics. [Retrieved 2015] 2014
   Google Scholar
• Vaginal and Vulvar Cancers Statistics. Available at http://www.cdc.gov/cancer/vagvulv/statistics. [Retrieved 2015] 2014
   Google Scholar
• Massad L. Outcomes After Diagnosis of Vaginal Intraepithelial Neoplasia. J Lower Genital Tract Dis 2008; 12:16-19; PMID:18162807; http://dx.doi.org/10.1097/LGT.0b013e318074f968
   PubMed Web of Science ®Google Scholar
• Gunderson C, Nugent E, Elfrink S, Gold M, Moore K. A contemporary analysis of epidemiology and management of vaginal intraepithelial neoplasia. Am J Obstetr Gynecol 2013; 208:410.e1-410.e6; PMID:23380265
   PubMed Web of Science ®Google Scholar
• Hoffman M, Decesare S, Roberts W, Fiorica J, Finan M, Cavanagh D. Upper vaginectomy for in situ and occult, superficially invasive carcinoma of the vagina. Am J Obstetr Gynecol 1992; 166:30-33; PMID:1733213; http://dx.doi.org/10.1016/0002-9378(92)91823-S
   PubMed Web of Science ®Google Scholar
• HPV Vaccination. (2010). Available at http://www.cdc.gov/vaccines/vpd-vac/hpv/ [Retrieved 2015]
   Google Scholar
• HPV (Human Papillomavirus) Cervarix®® VIS. (2013, June 18). Available at http://www.cdc.gov/vaccines/hcp/vis/vis-statements/hpv-Cervarix®.html. [Retrieved 2015]
   Google Scholar
• Atkinson W. Human Papillomavirus. In Epidemiology & prevention of vaccine-preventable diseases (13th ed.) 2015
   Google Scholar
• Kirnbauer, R, Booy, F, Cheng, N, Lowy, D, Schiller J. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci 1992:12180-12184
   PubMed Web of Science ®Google Scholar
• Ault K. Long-term efficacy of human papillomavirus vaccination. Gynecologic Oncol. 2007; 107:S27-S30; PMID:17938016; http://dx.doi.org/10.1016/j.ygyno.2007.07.078
   PubMedGoogle Scholar
• Naud P, Roteli-Martins C, Carvalho N, Teixeira J, Borba P, Sanchez N, Descamps D. Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine. Hum Vaccines Immunotherapeutics. 2014; 10:2147-2162; PMID:25424918; http://dx.doi.org/10.4161/hv.29532
   PubMed Web of Science ®Google Scholar
• Rahman M, Laz T, Mcgrath C, Berenson A. Correlates of human papillomavirus vaccine series completion among young adult female initiators. Hum Vacc Immunotherapeutics. 2014; 10:2163-2167; PMID:25424919; http://dx.doi.org/10.4161/hv.29633
   PubMed Web of Science ®Google Scholar
• Hendry M, Lewis R, Clements A, Damery S, Wilkinson C. “HPV? Never heard of it!:” A systematic review of girls' and parents' information needs, views and preferences about human papillomavirus vaccination. Vaccine 2013; 31(45):5152-5167; PMID:24029117; http://dx.doi.org/10.1016/j.vaccine.2013.08.091
   PubMed Web of Science ®Google Scholar
• Gillison M, Chaturvedi A, Lowy D. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008; 113:3036-3046; PMID:18980286; http://dx.doi.org/10.1002/cncr.23764
   PubMed Web of Science ®Google Scholar
• Garland S, Steben M, Sings H, James M, Lu S, Railkar R, Joura E. Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine. J Infect Dis 2009; 199:805-814; PMID:19199546; http://dx.doi.org/10.1086/597071
   PubMed Web of Science ®Google Scholar
• Serrano B, Alemany L, Tous S, Bruni L, Clifford G, Weiss T, Sanjosé S. Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease. Infectious Agents and Cancer Infect Agents Cancer 2012; 7:38-38; PMID:23273245; http://dx.doi.org/10.1186/1750-9378-7-38
   PubMed Web of Science ®Google Scholar
• Sanjosé S, Alemany L, Ordi J, Tous S, Alejo M, Bigby S, Bosch X. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer 2013; 49:3450-3461; http://dx.doi.org/10.1016/j.ejca.2013.06.033
   PubMed Web of Science ®Google Scholar
• Alemany L, Saunier M, Tinoco L, Quirós B, Alvarado-Cabrero I, Alejo M, Bosch X. Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples. Eur J Cancer 2014; 50:2846-2854; PMID:25155250; http://dx.doi.org/10.1016/j.ejca.2014.07.018
   PubMed Web of Science ®Google Scholar
• Garçon N, Wettendorff M, Mechelen M. Role of AS04 in human papillomavirus vaccine: Mode of action and clinical profile. Expert Opin Biol Ther Expert Opinion Biological Therapy 2011; 11:667-677; http://dx.doi.org/10.1517/14712598.2011.573624
   PubMed Web of Science ®Google Scholar
• Paavonen J, Naud P, Salmerón J, Wheeler C, Chow S, Apter D, Dubin G. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009; 374:301-314; PMID:19586656
   PubMed Web of Science ®Google Scholar
• FUTURE II Study Group. Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions. N Eng J Med 2007; 356:1915-1927; PMID:17494925
   PubMed Web of Science ®Google Scholar
• Garland S, Hernandez-Avila M, Wheeler C, Perez G, Harper D, Leodolter S, Koutsky L. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Eng J Med 2007; 356:1928-1943; PMID:17494926; http://dx.doi.org/10.1056/NEJMoa061760
   PubMed Web of Science ®Google Scholar
• Munoz NSK, Kjaer K, Sigurdsson OE, Iversen M, Hernandez-Avila CM, Wheeler G. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16–26 years. J Infect Dis 2009; 199:936-944; PMID:19236277
   PubMed Web of Science ®Google Scholar
• Tabrizi S, Brotherton J, Kaldor J, Skinner S, Cummins E, Liu B, Garland S. Fall in Human Papillomavirus Prevalence Following a National Vaccination Program. J Infect Dis. 2012; 206:1645-1651; PMID:23087430; http://dx.doi.org/10.1093/infdis/jis590
   PubMed Web of Science ®Google Scholar
• Ali H, Donovan B, Wand H, Read T, Regan D, Grulich A, Guy R. Genital warts in young Australians five years into national human papillomavirus vaccination programme: National surveillance data. Bmj 2013; 346:f2032
   PubMed Web of Science ®Google Scholar
• Teen Vaccination Coverage. (2015, July 30). Retrieved 2015, from http://www.cdc.gov/vaccines/who/teens/vaccination-coverage.html
   Google Scholar
• Broader disease coverage due to more HPV types. 2015. Retrieved 2015, from https://www.merckvaccines.com/Products/Gardasil9/Pages/why9
   Google Scholar
• Herweijer E, Leval A, Ploner A, Eloranta S, Simard J, Dillner J, Arnheim-Dahlström L. Association of Varying Number of Doses of Quadrivalent Human Papillomavirus Vaccine With Incidence of Condyloma. JAMA 2014; 311:597-603; PMID:24519299; http://dx.doi.org/10.1001/jama.2014.95
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. Vaginal Cancer treatment. Available at: http://cancer.gov/types/hp/vaginal-treatment; 2015. [Retrieved 2015]
   Google Scholar